{"disease":{"id":"hemostatic-agents","name":"hemostatic agents"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07232927","title":"Evaluation of Hemostatic Agents in Partial Nephrectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Ankara University","has_results":false},{"nct_id":"NCT07058727","title":"Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain","phase":"NA","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Cukurova University","has_results":false},{"nct_id":"NCT04309084","title":"Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"Celularity Incorporated","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}